1.The Unaudited Standalone Financial Results for the quarter ended 30th June, 2025 along with Limited Review Report thereon pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015. 2.Recommended ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 0.7 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved unaudited standalone financial results for Q1 FY26 (quarter ended 30 June 2025). The company reported revenue from operations of ₹632 lakhs, marking the first quarter of meaningful revenue (previous quarters showed nil revenue). Total income stood at ₹644 lakhs against total expenses of ₹678 lakhs, resulting in a net loss of ₹34 lakhs (EPS of ₹(0.05)). The loss has narrowed compared to the ₹40 lakh loss in Q1 FY25. The auditor (A. Sachdev & Co.) issued an unqualified limited review report. The board also approved the 36th AGM for 26 September 2025 (via OAVM), fixed book closure from 19–26 September 2025, re-appointed a retiring director, and named ATJ & Co. LLP as the new internal auditor and Mr. Pankaj S. Desai as secretarial auditor for five years (FY 2025-26 to FY 2029-30).
The company has begun generating revenue but is still operating at a loss, though the loss is shrinking compared to a year ago. For shareholders, the key thing to watch is whether the new revenue base scales enough to cover the ~₹678 lakh quarterly cost structure and turn profitable.